2019

F. Triposkiadis, J. Butler, F. M. Abboud, P. W. Armstrong, S. Adamopoulos, J. J. Atherton, J. Backs, J. Bauersachs, D. Burkhoff, R. O. Bonow, V. K. Chopra, R. A. de Boer, L. de Windt, N. Hamdani, G. Hasenfuss, S. Heymans, J. S. Hulot, M. Konstam, R. T. Lee, W. A. Linke, I. G. Lunde, A. R. Lyon, C. Maack, D. L. Mann, A. Mebazaa, R. J. Mentz, P. Nihoyannopoulos, Z. Papp, J. Parissis, T. Pedrazzini, G. Rosano, J. Rouleau, P.M. Seferovic, A. M. Shah, R. C. Starling, C. G. Tocchetti, J. N. Trochu, T. Thum, F. Zannad, D. L. Brutsaert, V. F. Segers, G. W. de Keulenaer. "The continuous heart failure spectrum: moving beyond an ejection fraction classification. European Heart Journal (2019) 00, 1–1. DOI: 10.1093/eurheartj/ehz158. IF: 23.425

G. Fülöp, F. Ramirez-Perez, T. Kiss, S. Tarantini, M. Valcarcel Ares, P. Tóth, A. Yabluchanskiy, S. Conley, P. Ballabh, L. A. Martinez-Lemus, Z. Ungvári, A. Csiszár. "IGF-1 deficiency promotes pathological remodeling of cerebral arteries: a potential mechanism contributing to the pathogenesis of intracerebral hemorrhages in aging." The Journals of Gerontology: Series A 74 (2019): 446–454. DOI: 10.1093/gerona/gly144. IF: 4.902

M. Ruppert, B. Bódi, S. Korkmaz-Icöz, S. Loganathan, W. Jiang, L. Lehmann, A. Oláh, B. Barta, A. Sayour, B. Merkely, M. Karck, Z. Papp,G. Szabó, T. Radovits. "Myofilament Ca2+ sensitivity correlates with left ventricular contractility during the progression of pressure overload-induced left ventricular myocardial hypertrophy in rats." Journal of Molecular and Cellular Cardiology 129 (2019): 208-218. DOI: 10.1016/j.yjmcc.2019.02.017. IF: 5.296 

M. Bombicz, D. Priksz, R. Gesztelyi, R. Kiss, N. Hollós, B. Varga, J. Németh, A. Tóth, Z. Papp, Z. Szilvássy, B. Juhász. "The drug candidate BGP-15 delays the onset of diastolic dysfunction in the Goto-Kakizaki rat model of diabetic cardiomyopathy." Molecules 24, no. 3 (2019): 1-18.  DOI: 10.3390/molecules24030586. IF: 3.098

2018

L. Balogh, É. Katona, Z. A. Mezei, J. Kállai, R. Gindele, I. Édes, L. Muszbek, Z. Papp, Z. Bereczky. "Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients." Molecular and Cellular Biochemistry, (2018) DOI: 10.1007/s11010-018-3326-8. IF: 2.669

A. Csongrádi, A. Enyedi, I. Takács, T. Végh, I. S. Mányiné, Z. Pólik, I. T. Altorjay, J. Balla, G. Balla, I. Édes, J. Kappelmayer, A. Tóth, Z. Papp, M. Fagyas. "Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis." Clinical Chemistry and Laboratory Medicine, (2018) DOI: 10.1515/cclm-2017-0837. IF: 3.432

J. Altenberger, F. Gustafsson, V. P. Harjola, K. Karason, D. Kindgen-Milles, M. Kivikko, G. Malfatto, Z. Papp, J. Parissis, P. Pollesello, G. Pölzl, C. Tschöpe. "Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications." Journal of Cardiovascular Pharmacology 71, no. 3 (2018):129-136. DOI: 10.1097/FJC.0000000000000533. IF: 2.247

S. Tarantini, A. Yabluchanskiy, G. Fülöp, P. Hertelendy, N. M. Valcarcel-Ares, T. Kiss, J. M. Bagwell, D. O'Connor, E. Farkas, F. Sorond, A. Csiszar, Z. Ungvari. "Correction to: Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice." Geroscience, (2018) DOI: 10.1007/s11357-018-0012-4. IF: 2.123

S. Tarantini, N. M. Valcarcel-Ares, A. Yabluchanskiy, G. Fulop, P. Hertelendy, T. Gautam, E. Farkas, A. Perz, P. S. Rabinovitch, W. E. Sonntag, A. Csiszar, Z. Ungvari. "Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice." Aging Cell no. 17 (2018): e12731. DOI: 10.1111/acel.12731. IF: 6.714

L. Nagy, J. Márton, A. Vida, G. Kis, É. Bokor, S. Kun, M. Gönczi, T. Docsa, A. Tóth, M. Antal, P. Gergely, B. Csóka, P. Pacher, L. Somsák, P. Bai "Glycogen phosphorylase inhibition improves β‐cell function." Journal of Neurotrauma 34, no. 2 (2018): 529-534. DOI: 10.1111/bph.13819. IF: 5.19

Z. Simándi, K. Pájer, K. Károlyi, T. Sieler, L. Jiang, Z. Kolostyák, Z. Sári, Z. Fekecs, A. Pap, A. Patsalos, G. Contreras, B. Rehó, Z. Papp, X. Guo, A. Horváth, G. Kiss, Z. Keresztessy, G. Vámosi, J. Hickman, H. Xu, D. Dormann, T. Hortobágyi, M. Antal, A. Nógrádi, L. Nagy. "Arginine Methyltransferase PRMT8 Provides Cellular Stress Tolerance in Aging Motoneurons. " Journal of Neuroscience 38, no. 35 (2018): 7683-7700. DOI: org/10.1523/JNEUROSCI.3389-17.2018. IF: 5.97

Z. Papp, T. Radovits, W. Paulus, N. Hamdani, P. Seferovic. "Molecular and pathophysiological links between heart failure with preserved ejection fraction and type 2 diabetes mellitus." European Journal of Heart Failure no. 1-4 (2018). DOI: 10.1002/ejhf.1318 IF: 10.683

J. Márton, M. Péter, G. Balogh, B. Bódi, A. Vida, M. Szántó, D. Bojcsuk, L. Jankó, H. Bhattoa, I. Gombos, K. Uray, I. Horváth, Z. Török, B. Bálint, Z. Papp, L. Vígh, P. Bai. "Poly(ADP-ribose) polymerase-2 is a lipid-modulated modulator of muscular lipid homeostasis."Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids 1863 no. 11 (2018): 1399-1412, DOI: 10.1016/j.bbalip.2018.07.013. IF: 4.966

D. Priksz, M. Bombicz, B. Varga, A. Kurucz, R. Gesztelyi, J. Balla, A. Tóth, Z. Papp, Z. Szilvássy, B. Juhász. "Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease. " International Journal of Molecular Sciences 19 no. 10 (2018): 1-18, DOI: 10.3390/ijms19102882. IF: 3.687

S. Bouchez, F. Fedele, G. Giannakoulas, F. Gustafsson, V.-P. Harjola, K. Karason, M. Kivikko, D. von Lewinski, F. Oliva, Z. Papp, J. Parissis, Piero Pollesello, G. Pölzl, C. Tschöpe. "Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application." Cardiovascular Drugs and Therapy 32, no. 6 (2018): 617-624. DOI: 10.1007/s10557-018-6838-2. IF: 2.771

C. Maack, T. Eschenhagen, N. Hamdani, F. R. Heinzel, A. R. Lyon, D. J. Manstein, J. Metzger, Z. Papp, C. G. Tocchetti, M. Birhan Yilmaz, S. D. Anker, J. Balligand, J. Bauersachs, D. Brutsaert L. Carrier, S. Chlopicki, J. G Cleland, R. A. de Boer, A. Dietl, R. Fischmeister, V. Harjola, S. Heymans, D. Hilfiker-Kleiner, J. Holzmeister, G. de Keulenaer, G. Limongelli, W. A. Linke, L. H. Lund, J. Masip, M. Metra, C. Mueller, B. Pieske, P. Ponikowski, A. Ristić, F. Ruschitzka, P. M. Seferović, H. Skouri, W. H Zimmermann, A. Mebazaa. "Treatments targeting inotropy." European Heart Journal, (2018) DOI: 10.1093/eurheartj/ehy600. IF: 23.425

T. Csipo, G. A. Fulop, A. Lipecz, S. Tarantini, T. Kiss, P. Balasubramanian, A. Csiszar, Z. Ungvari, A. Yabluchanskiy."Short-term weight loss reverses obesity-induced microvascular endothelial dysfunction." Geroscience 40 (2018):337–346. DOI: 10.1007/s11357-018-0028-9. IF: 2.123

G. A. Fulop, T. Kiss, S. Tarantini, P. Balasubramanian, A. Yabluchanskiy, E. Farkas, F. Bari, Z. Ungvari, A. Csiszar. "Nrf2 deficiency in aged mice exacerbates cellular senescence promoting cerebrovascular inflammation." Geroscience 40 (2018):513–521. DOI: 10.1007/s11357-018-0047-6. IF: 2.123

S. Tarantini, A. Yabluchanskiy, G. A. Fülöp, T. Kiss, A. Perz, D. O’Connor, E. Johnson, F. Sorond, Z. Ungvari, A. Csiszar. "Age-Related Alterations in Gait Function in Freely Moving Male C57BL/6 Mice: Translational Relevance of Decreased Cadence and Increased Gait Variability" Journals of Gerontology Series A-Biological Sciences and Medical Sciences (2018) DOI:10.1093/gerona/gly242. IF: 4.902

G. A.  Fulop, F. I.  Ramirez-Perez, T. Kiss, S. Tarantini, N. M. Valcarcel-Ares, P. Toth, A. Yabluchanskiy, S. M. Conley, P. Ballabh, L. A. Martinez-Lemus, Z. Ungvari, A. Csiszar. "IGF-1 Deficiency Promotes Pathological Remodeling of Cerebral Arteries: A Potential Mechanism Contributing to the Pathogenesis of Intracerebral Hemorrhages in Aging" Journals of Gerontology Series A-Biological Sciences and Medical Sciences (2018) DOI:10.1093/gerona/gly144. IF: 4.902

S. Tarantini, N. M. Valcarcel-Ares, A. Yabluchanskiy, G. A. Fulop, P. Hertelendy, T. Gautam, E. Farkas A. Perz, P. S. Rabinovitch, W. E. Sonntag, A. Csiszar, Z. Ungvari. "Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice" Aging Cell (2018) DOI: 10.1111/acel.12731. IF: 7.627


 

2017

B. Bódi, E. Pásztorné Tóth, L. Nagy, A. Tóth, L. Mártha, Á. Kovács, G. Balla, T. Kovács, Z. Papp. "Titin isoforms are increasingly protected against oxidative modifications in developing rat cardiomyocytes." Free Radical Biology & Medicine: no. 113 (2017): 224-235. DOI: 10.1016/j.freeradbiomed.2017.09.015. IF: 5.606

M. Szokol, D. Priksz, M. Bombicz, B. Varga, Á. Kovács, G. Fülöp, T. Csípő, A. Pósa, A. Tóth, Z. Papp, Z. Szilvássy, B. Juhász. "Long term osmotic mini pump treatment with alpha-MSH improves myocardial function in Zucker Diabetic Fatty rats." Molecules 22, no.10 (2017): pii: E1702. DOI: 10.3390/molecules22101702. IF: 2.861

V. Harjola, W. Mullens, M. Banaszewski, J. Bauersachs, Hans-Peter Brunner-La Rocca, O. Chioncel, S. Collins, W. Doehner, G. Filippatos, A. Flammer, V. Fuhrmann, M. Lainscak, J. Lassus, M. Legrand, J. Masip, C. Mueller, Z. Papp, J. Parissis, E. Platz, A. Rudiger, F. Ruschitzka, A. Schäfer, P. Seferovic, H. Skouri, M. Yilmaz, A. Mebazaa. "Organ dysfunction, injury and failure in acute heart failure: From pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)." European Journal of Heart Failure 19, no. 7 (2017): 821-836. DOI: 10.1002/ejhf.872. IF: 6.968

A. Patsalos, A. Pap, T. Varga, G. Trencsényi, G. Contreras, I. Garai, Z. Papp, B. Dezső, É. Pintye, L. Nagy. "In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury." Journal of Physiology 595, no. 17 (2017): 5815-5842. DOI: 10.1113/JP274361. IF: 4.739

G. Pölzl, J. Altenberger, L. Baholli, P. Beltrán, A. Borbély, J. Comin-Colet, J. Delgado, F. Fedele, A.  Fontana, F. Fruhwald, G. Giamouzis, G. Giannakoulas, M. Garcia-González, F. Gustafsson, K. Kaikkonen, M. Kivikko, J. Kubica, D. von Lewinski, I. Löfman, G. Malfatto, N. Manito, M. Martínez-Sellés, J. Masip, B. Merkely, F. Morandi, H. Mlgaard, F. Oliva, E. Pantev, Z. Papp, G. Perna, R. Pfister, V. Piazza, R. Bover, D. Rangel-Sousa, A. Recio-Mayoral, A. Reinecke, A. Rieth, T. Sarapohja, G.  Schmidt, M. Seidel, S. Störk, B. Vrtovec, G. Wikström, P. Yerly, P. Pollesello. "Repetitive use of levosimendan in advanced heart failure: Need for stronger evidence in a field in dire need of a useful therapy." International Journal of Cardiology no. 243 (2017):389-395. DOI: 10.1016/j.ijcard.2017.05.081. IF: 6.189

J. Altenberger, F. Gustafsson, V. Harjola, K. Karason, D. Kindgen-Milles, M. Kivikko, G. Malfatto, Z. Papp, J. Parissis, P. Pollesello, G. Pölzl, C. Tschöpe. "Levosimendan in acute and advanced heart failure: An appraisal of the clinical database and evaluation of its therapeutic applications." Journal of Cardiovascular Pharmacology 71, no. 3 (2017):129-136. DOI: 10.1097/FJC.0000000000000533. IF: 2.247

C. Mátyás, B. Németh, A. Oláh, M. Török, M. Ruppert, D. Kellermayer, B. Barta, G. Szabó, G. Kökény, E. Horváth, B. Bódi, Z. Papp, B. Merkely, T. Radovits. "Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes." European Journal of Heart Failure 19, no. 3 (2017): 326-336. DOI: 10.1002/ejhf.711. IF: 6.968

L. Nagy, I. Gödény, P. Nánási, Á. Leskó, L. Balogh, V. Bánhegyi, B. Bódi, T. Csípő, A. Csongrádi, G. Fülöp, Á. Kovács, M. Lódi, Z. Papp. "A szív pozitív inotróp támogatása a miozin-aktivátor hatású omecamtiv-mecarbil segítségével." Cardiologica Hungarica no. 47 (2017): 145–152. DOI: 10.26430/CHUNGARICA.2017.47.2.145

Á. Kovács, J. Kalász, E. Pásztorné Tóth, A. Tóth, Z. Papp, N. Dhalla, J. Barta. "Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca2+-paradox rat hearts." Molecular and Cellular Biochemistry 403, no. 1-2 (2017): 57-68. DOI: 10.1007/s11010-017-2954-8 IF: 2.669

P. Cseplo, Z. Vamos, O. Torok, I. Ivic, A. Toth, A. Buki, A. Koller "Hemolyzed Blood Elicits a Calcium Antagonist and High CO2 Reversible Constriction via Elevation of [Ca2+] i in Isolated Cerebral Arteries" Journal of Neurotrauma 34, no. 2 (2017): 529-534. DOI: 10.1089/neu.2015.4365. IF: 5.19

B. Horváth, N. Szentandrássy, R. Veress, J. Almássy, J. Magyar, T. Bányász, A. Tóth Z. Papp, P. Nánási. "Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. " Naunyn-Schmiedebergs Archives of Pharmacology 390, no.12 (2017):1239-1246. DOI: 10.1007/s00210-017-1422-z. IF: 2.558

Z. Ungvari, M. N. Valcarcel-Ares, S. Tarantini, A. Yabluchanskiy, G. Fülöp, T. Kiss, A. Csiszar. "Connective tissue growth factor (CTGF) in age-related vascular pathologies." Geroscience. 39, no. 5-6 (2017):491-498. doi: 10.1007/s11357-017-9995-5. DOI: 10.1007/s11357-017-9995-5. IF: 2.123

G. Fülöp and A. Yabluchanskiy. "Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension." American Journal of Physiology Heart and Circulatory Physiology 313, no. 2 (2017): H251-H255. DOI: 10.1152/ajpheart.00320.2017. IF: 3.348

S. Tarantini, N. M. Valcarcel-Ares, A. Yabluchanskiy, Z. Springo, G. Fulop, N. Ashpole, T. Gautam, C. B. Giles, J. D. Wren, W. E. Sonntag, A. Csiszar, Z. Ungvari. "Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype." Aging Cell 16, no. 3 (2017): 469-479. DOI: 10.1111/acel.12583. IF: 6.714

M. Vecsernyes, M. Szokol, M. Bombicz, D. Priksz, R. Gesztelyi, G. Fulop, B. Varga, B. Juhasz, D. Haines, A. Tosaki. "Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts." Journal of Cardiovascular Pharmacology 69, no. 5 (2017): 286-297. DOI: 10.1097/FJC.0000000000000472. IF: 2.247

Z. Ungvari, S. Tarantini, P. Hertelendy, M. N. Valcarcel-Ares, G. Fülöp, S. Logan, T. Kiss, E. Farkas A. Csiszar, A. Yabluchanskiy. "Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence." Geroscience 39, no. 1 (2017): 33-42. DOI: 10.1007/s11357-017-9964-z. IF: 2.123

S. Tarantini, G. Fulop, T. Kiss, E. Farkas, D. Zölei-Szénási, V. Galvan, P. Toth, A. Csiszar, Z. Ungvari, A. Yabluchanskiy. "Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer's disease using functional laser speckle contrast imaging." Geroscience 39 (2017):465–473. DOI: 10.1007/s11357-017-9980-z. IF: 2.123

Z. Tucsek, M. N. Valcarcel-Ares, S. Tarantini, A. Yabluchanskiy, G. Fülöp, T. Gautam, A. Orock, A. Csiszar, F. Deak, Z. Ungvari. "Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment." Geroscience 39 (2017):385–406 DOI: 10.1007/s11357-017-9981-y. IF: 2.123

A. Csiszar, S. Tarantini, G. Fülöp, T. Kiss, M. N. Valcarcel-Ares, V. Galvan, Z. Ungvari, A.  Yabluchanskiy. "Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease." Geroscience 39 (2017):359–372 DOI: 10.1007/s11357-017-9991-9. IF: 2.123

S. Tarantini, A. Yabluchanksiy, G. Fülöp, P. Hertelendy, M. N. Valcarcel-Ares, T. Kiss, J. M. Bagwell, D. O'Connor, E. Farkas, F. Sorond, A. Csiszar, Z. Ungvari. "Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice." Geroscience 39, no. 5-6 (2017): 601-614. DOI: 10.1007/s11357-017-0003-x. IF: 2.123

M. Fagyas "A Pitvarfibrilláció gyógyszeres kezelésének hatásai" Metabolizmus XV. évfolyam, 3. szám, 139-X (2017)
 

2016

S. von Haehling, Z. Papp, S. Anker. "ESC Heart Failure A new journal aims to broaden heart failure views." European Journal of Heart Failure 18, no.12 (2016): 1415-1419. DOI: 10.1002/ejhf.692. IF: 6.968

D. Farmakis, J. Alvarez, T. Gal, D. Brito, F. Fedele, C. Fonseca, A. Gordon, I. Gotsman, E. Grossini, F. Guarracino, V. Harjola, Y. Hellman, L. Heunks, V. Ivancan, A. Karavidas, M. Kivikko, V. Lomivorotov, D. Longrois, J. Masip, M. Metra, A. Morelli, M. Nikolaou, Z. Papp, A. Parkhomenko, G. Poelzl, P. Pollesello, H. Ravn, S. Rex, H. Riha, S. Ricksten, R. Schwinger, B. Vrtovec, M. Yilmaz, M. Zielinska, J. Parissis. "Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: an expert panel position paper." International Journal of Cardiology no. 222 (2016): 303-312. DOI: 10.1016/j.ijcard.2016.07.202. IF: 6.189

P. Pollesello, Z. Papp, G. Papp. "Calcium sensitizers: What have we learned over the last 25years?" International Journal of Cardiology no. 203 (2016): 543-548. DOI: 10.1016/j.ijcard.2015.10.240. IF: 6.189

L. Nagy, P. Pollesello, H. Haikala, Á. Végh, T. Sorsa, J. Levijoki, S. Szilágyi, I. Édes, A. Tóth, Z. Papp, G. Papp. "ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropy." European Journal of Pharmacology no. 775 (2016): 120-129. DOI: org/10.1016/j.ejphar.2016.02.028. IF: 2.896

N. Szentandrássy, B. Horváth, K. Váczi, K. Kistamás, L. Masuda, J. Magyar, T. Bányász, Z. Papp, P. Nánási. "Dose-dependent electrophysiological effects of the myosin activator omecamtiv mecarbil in canine ventricular cardiomyocytes." Journal of Physiology and Pharmacology 67, no. 4 (2016): 483-489. IF: 2.883

J. Pitha, L. Králová, J. Hubáček, A. Sekerková, V. Lánská, V. Adámková, M. Dorobantu, R. Nicolescu, R. Steiner, V. Ivić, A. Borbély, Z. Papp, S. Vári. "Smoking impairs and circulating stem cells favour the protective effect of the T allele of the connexin37 gene in ischemic heart disease: A multinational study." Atherosclerosis no. 244 (2016): 73-78. DOI: 10.1016/j.atherosclerosis.2015.11.007. IF: 4.239

K. Úri, M. Fagyas, A. Kertész, A. Borbély, C. Jenei, O. Bene, Z. Csanádi, W. Paulus, I. Édes, Z. Papp, A. Tóth, E. Lizanecz. "Circulating ACE2 activity correlates with cardiovascular disease development." Journal of Renin-Angiotensin-Aldostrein System 17, no. 4 (2016): 1-11. DOI: 10.1177/1470320316668435. IF: 1.396

Á. Kovács, G. Fülöp, A. Kovács, T. Csípő, B. Bódi, D. Priksz, B. Juhász, L. Beke, Z. Hendrik, G. Méhes, H. Granzier, I. Édes, M. Fagyas, Z. Papp, J. Barta, A. Tóth. "Renin overexpression leads to increased titin-based stiffness contributing to diastolic dysfunction in hypertensive mRen2 rats." American Journal of Physiology Heart and Circulatory Physiology 310, no. 11 (2016): H1671-H1682. DOI: 10.1152/ajpheart.00842.2015. IF: 3.348

P. Nánási, K. Váczi, Z. Papp. "The myosin activator omecamtiv mecarbil: A promising new inotropic agent." Canadian Journal of Physiology and Pharmacology 94, no. 10 (2016): 1033-1039. DOI: 10.1139/cjpp-2015-0573. IF: 1.822
R. Fedor, D. Kovács, L. Lőcsey, M. Fagyas, L. Asztalos, A. Tóth. "Az angiotenzinkonvertálóenzim-gén I/D polimorfizmusának hatása a vesetranszplantált betegek cardiovascularis rizikójára és a grafttúlélésre." Orvosi Hetilap 157, no. 24 (2016): 938-945. DOI.org/10.1556/650.2016.30496. IF: 0.349

Á. Kovács, A. Alogna, H. Post, N. Hamdani. "Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?" Netherlands Heart Journal 24, no. 4 (2016): 268-274. DOI: 10.1007/s12471-016-0814-x. IF: 1.894

P. Cséplő, Z. Vámos, I. Ivic, O. Török, A. Tóth, Á. Koller. "The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i." PLoS One no. 11, (2016): 1-22. DOI: 10.1371/journal.pone.0164010. IF: 2.806

O. Abdul-Rahman, E. Kristóf, Q. Doan-Xuan A. Vida, L. Nagy, A. Horváth, J. Simon, T. Maros, I. Szentkirályi, L. Palotás, T. Debreceni, P. Csizmadia, T. Szerafin, T. Fodor, M. Szántó, A. Tóth, B. Kiss, Z. Bacsó, P. Bai. "AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype." PLoS One 11, no. 6 (2016): e0157644. DOI: 10.1371/journal.pone.0157644. IF: 2.806

K. Khavandi, R. A. Baylie, S. A. Sugden, M. Ahmed, V. Csato, P. Eaton, D. C. Hill-Eubanks, A. D. Bonev, M. T. Nelson, A. S. Greenstein. "Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels." Science Signaling 11, no. 9 (2016): 449ra100. DOI: 10.1126/scisignal.aaf6625. IF: 6.494

R. Fedor, D. Á. Kovács, L. Lőcsey, M. Fagyas, L. Asztalos, A. Tóth. "The effect of the I/D polymorphism of the angiotensin-converting enzyme gene on the cardiovascular risk and graft survival of kidney transplant patients." Orvosi Hetilap 157, no. 24 (2016):938-45. DOI: 10.1556/650.2016.30496.

B. Lelesz, Z. Szilvássy, G. K. Tóth, A. Tóth, A. Enyedi, E. Felszeghy, A. Varga, B. Juhász, J. Németh. "Radioanalytical methods for the measurement of melanin concentrating hormone (MCH) and detection its receptor in rat tissues" Journal of Radioanalytical and Nuclear Chemistry 310, no. 3 (2016): 1325-1333. DOI 10.1007/s10967-016-4952-9. IF: 1.282
 

2015

Á. Balogh, I. Édes, Z. Papp. "A posztinfarktusos remodelláció celluláris és molekuláris aspektusai." Cardiologica Hungarica 45 (2015): 274-279.

L. Nagy, Á. Kovács, B. Bódi, E. Pásztorné Tóth, G. Fülöp, A. Tóth, I. Édes, Z. Papp. "The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat." British Journal of Pharmacology 172, no. 18 (2015): 4506-4518. DOI: 10.1111/bph.13235. IF: 5.259

M. Balog, M. Miljanović, S. Blažetić, I. Labak, V. Ivić, B. Viljetić, A. Borbély, Z. Papp, R. Blazeković, S. Vári, M. Fagyas, M. Heffer. "Sex-specific chronic stress response at the level of adrenal gland modifies sexual hormone and leptin receptors." Croatian Medical Journal 56, no. 2 (2015): 104-113. DOI:10.3325/cmj.2015.56.10. IF: 1.483

G. Alvarado, V. Jeney, A. Tóth, É. Csősz, G. Kalló, A. Huynh, C. Hajnal, J. Kalász, E. Pásztorné Tóth,  I. Édes, M. Gram, B. Akerström, A. Smith, J. Eaton, G. Balla, Z. Papp, J. Balla. "Heme-induced contractile dysfunction in Human cardiomyocytes caused by oxidant damage to thick filament proteins." Free Radical Biology and Medicine no. 89 (2015): 248-262. DOI: 10.1016/j.freeradbiomed.2015.07.158 IF: 5.784

J. Kalász, E. Pásztorné Tóth, M. Fagyas, Á. Balogh, A. Tóth, V. Csató, I. Édes, Z. Papp, A. Borbély. "Myeloperoxidase impairs the contractile function in isolated human cardiomyocytes." Free Radical Biology and Medicine no. 84 (2015): 116-127. DOI: 10.1016/j.freeradbiomed.2015.02.036. IF: 5.784

V. Csató, A. Pető, G. Fülöp, I. Rutkai, E. Pásztorné Tóth, M. Fagyas, J. Kalász, I. Édes, A. Tóth, Z.  Papp. "Myeloperoxidase evokes substantial vasomotor responses in isolated skeletal muscle arterioles of the rat." Acta Physiologica 214, no. 1 (2015): 109-123. DOI: 10.1111/apha.12488. IF: 4.066

J. Barta, Á. Kovács. "Szívelégtelenség és cilostazol." Cardiologica Hungarica 45, no. 2 (2015): 108-116.
 

2014

E. Bányai, E. Balogh, M. Fagyas, P. Arosio, Z. Hendrik, G. Király, G. Nagy, B. Tánczos, I. Pócsi,G.  Balla, J. Balla, G. Bánfalvi, V. Jeney. "Novel functional changes during podocyte differentiation: increase of oxidative resistance and H-ferritin expression." Oxidative Medicine and Cellular Longevity 2014 (2014): 976394. DOI: 10.1155/2014/976394. IF: 4.593

V. Csato, A. Peto, A. Koller, I. Edes, A. Toth and Z. Papp. "Hydrogen peroxide elicits constriction of skeletal muscle arterioles by activating the arachidonic Acid pathway." PLoS One 9, no. 8 (2014): e103858. DOI: 10.1371/journal.pone.0103858. IF: 3.234

M. Fagyas, K. Uri, I. M. Siket, A. Darago, J. Boczan, E. Banyai, I. Edes, Z. Papp and A. Toth. "New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition." PLoS One 9, no. 4 (2014): e87843. DOI: 10.1371/journal.pone.0087843. IF: 3.234

M. Fagyas, K. Uri, I. M. Siket, A. Darago, J. Boczan, E. Banyai, I. Edes, Z. Papp and A. Toth (2014). "New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases." PLoS One 9, no. 4 (2014): e93719. DOI: 10.1371/journal.pone.0093719. IF: 3.234

M. Fagyas, K. Uri, I. M. Siket, G. A. Fulop, V. Csato, A. Darago, J. Boczan, E. Banyai, I. E. Szentkiralyi, T. M. Maros, T. Szerafin, I. Edes, Z. Papp and A. Toth. "New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human." PLoS One 9, no. 4 (2014): e87844. DOI: 10.1371/journal.pone.0087844. IF: 3.234

Á. Kovács, Z. Papp and L. Nagy. "Causes and Pathophysiology of Heart Failure with Preserved Ejection Fraction." Heart Failure Clinics 10, no. 3 (2014):389-98. DOI: 10.1016/j.hfc.2014.04.002. IF: 1.844

L. Nagy, P. Pollesello and Z. Papp. "Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus." Journal of Cardiovascular Pharmacology 64, no. 3 (2014):199-208. DOI: 10.1097/FJC.0000000000000113. IF: 2.135

Z. Papp, A. Borbély and W. J. Paulus. "CrossTalk opposing view: The late sodium current is not an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction)." The Journal of Physiology 592, no. 3 (2014): 415-417. DOI: 10.1113/jphysiol.2013.262261. IF: 5.037

A. Toth, A. Czikora, E. T. Pasztor, B. Dienes, P. Bai, L. Csernoch, I. Rutkai, V. Csato, I. S. Manyine, R. Porszasz, I. Edes, Z. Papp and J. Boczan. "Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat." Journal of Histochemistry and Cytochemistry 62, no. 2 (2014): 129-144. DOI: 10.1369/0022155413513589. IF: 1.959

K. Uri, M. Fagyas, I. Manyine Siket, A. Kertesz, Z. Csanadi, G. Sandorfi, M. Clemens, R. Fedor, Z. Papp, I. Edes, A. Toth and E. Lizanecz. "New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure." PLoS One 9, no. 4 (2014): e87845. DOI: 10.1371/journal.pone.0087845. IF: 3.234

Z. Papp, J. van der Velden, A. Borbély, I. Édes, G. J. M. Stienen. "Altered myocardial force generation in end-stage human heart failure. " ESC Heart Failure 1, no. 2 (2014): 160-165. DOI: 10.1002/ehf2.12020.

Z. Papp, A.  Borbély, W. J. Paulus. "Rebuttal from Zoltán Papp, Attila Borbély and Walter J. Paulus. " Journal of Physiology 592, no. 3 (2014): 421-422.

J. Kalász, E. Pásztorné Tóth, A. Tóth, B. Bódi, M. Fagyas, H. Bhattoa, S. Vári, M. Balog, S. Blažetić, M. Heffer, Z. Papp, A. Borbély. "Single acute stress-induced progesterone and ovariectomy alter cardiomyocyte contractile function in female rats." Croatian Medical Journal 55, no. 3 (2014): 239-249. DOI: 10.3325/cmj.2014.55.239. IF: 1.305

B. Bodnár, N. Geyer, O. Ruzsnavszky, T. Oláh, B. Hegyi, M. Sztretye, J. Fodor, B. Dienes, Á. Balogh,  Z. Papp, L. Szabó, G. Müller, L. Csernoch, P. Szentesi. "Hypermuscular mice with mutation in the myostatin gene display altered calcium signaling." Journal of Physiology 592, no. 6 (2014): 1353-1365. DOI: 10.1113/jphysiol.2013.261958. IF: 5.037

Á. Balogh, A. Tóth, E. Pásztorné Tóth, L. Nagy, Á. Kovács, J. Kalász, G. A. Contreras, I. Édes, Z. Papp. "Myofilament carbonylation modulates contractility in human cardiomyocytes." Experimental and Clinical Cardiology 20, no. 1 (2014): 2026-2035.

M. Hohl, H. Ardehali, F. Azuaje, R. Breckenridge, W. Doehner, P. Eaton, G. Ehret, T. Fujita, R. Gaetani, M. Giacca, G. Hasenfuß, S. Heymans, A. Leite-Moreira, W. Linke, D. Linz, A. Lyon, M. Mamas, M. Orešič, Z. Papp, T. Pedrazzini, M. Piepoli, B. Prosser, R. Rizzuto, G. Tarone, R. Tian, E. van Craenenbroeck, E. van Rooij, T. Wai, G. Weiss, C. Maack. "Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research."  European Journal of Heart Failure 16, no. 1 (2014): 6-14. DOI: 10.1002/ejhf.10 IF: 6.526

Anker SD, von Haehling S, Papp Z. "Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure." ESC Heart Failure1, no. 1 (2014):1-3. DOI 10.1002/ehf2.12004.

E. Bányai, E. Balogh, M. Fagyas, P. Arosio, Z. Hendrik, G. Király, G. Szemán-Nagy, B. Tánczos, I. Pócsi, G. Balla, J. Balla, G. Bánfalvi, V. Jeney. "Novel functional changes during podocyte differentiation: Increase of oxidative resistance and H-ferritin expression. "Oxidative Medicine and Cellular Longevity 2014, no. 1-10 (2014): 976394. DOI: 10.1155/2014/976394. IF: 3.516
 

2013

A. Czikora, I. Rutkai, E. T. Pasztor, A. Szalai, R. Porszasz, J. Boczan, I. Edes, Z. Papp and A. Toth. "Different desensitization patterns for sensory and vascular TRPV1 populations in the rat: expression, localization and functional consequences." PLoS One 8, no. 11 (2013): e78184. DOI: 10.1371/journal.pone.0078184. IF: 3.534

I. Godeny, P. Pollesello, I. Edes, Z. Papp and Z. Bagi. "Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo." Pharmacological Reports 65. no. 5 (2013): 1304-1310. IF: 2.165

P. Pollesello, Z. Papp and M. S. Nieminen. "Lessons from Lisbon on AHF drug treatment: Is it really true that all-oldfailed-all-new-will-succeed." International Journal of Cardiology 168: 4798-4799. DOI: 10.1016/j.ijcard.2013.07.042. IF: 6.175

P. M. Seferović, S. Stoerk, G. Filippatos, V. Mareev, A. Kavoliuniene, A. D. Ristić, P. Ponikowski, J. McMurray, A. Maggioni and F. Ruschitzka, D. J. van Veldhuisen, A. Coats, M. Piepoli, T. McDonagh, J. Riley, A. Hoes, B. Pieske, M. Dobric, Z. Papp, A. Mebazaa, J. Parissis, T. Ben Gal, D. Vinereanu, D. Brito, J. Altenberger, P. Gatzov, I. Milinkovic, J. Hradec, J. N. Trochu, O. Amir, B. Moura, M. Lainscak, J. Comin, G. Wilkström, S. Anker. "Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups." European journal of Heart Failure 15, no. 9 (2013): 947-959. DOI: 10.1093/eurjhf/hft092. IF: 6.175

S. Vandenwijngaert, P. Pokreisz, H. Hermans, H. Gillijns, M. Pellens, N. A. Bax, G. Coppiello, W. Oosterlinck, A. Balogh and Z. Papp. "Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling." PLoS One 8, no. 3 (2013): e58841. DOI: 10.1371/journal.pone.0058841. IF: 3.534

A. Balogh, D. Santer, E. T. Pasztor, A. Toth, D. Czuriga, B. K. Podesser, K. Trescher, K. Jaquet, F. Erdodi, I. Edes and Z. Papp. "Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts." Cardiovascular Research 101, no. 1 (2013): 108-119. DOI: 10.1093/cvr/cvt236. IF: 5.94
 

2012

A. Czikora, E. Lizanecz, P. Bako, I. Rutkai, F. Ruzsnavszky, J. Magyar, R. Porszasz, T. Kark, A. Facsko, Z. Papp, I. Edes and A. Toth. "Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1." British Journal of Pharmacology 165, no. 6 (2012): 1801-1812. DOI: 10.1111/j.1476-5381.2011.01645.x. IF: 4.409

A. Czikora, E. Lizanecz, J. Boczan, A. Darago, Z. Papp, I. Edes and A. Toth. "Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation." Life Sciences 90, no.11-12 (2012): 407-415. DOI: 10.1016/j.lfs.2011.12.016. IF: 2.527

D. Czuriga, W. J Paulus, I. Czuriga, I. Edes, Z. Papp and A. Borbély. "Cellular mechanisms for diastolic dysfunction in the human heart." Current Pharmaceutical Biotechnology 13, no. 13 (2012): 2532-2538. DOI: 10.2174/1389201011208062532. IF: 2.805

D. Czuriga, A. Toth, E. T. Pasztor, A. Balogh, A. Bodnar, E. Nizsaloczki, V. Lionetti, F. A. Recchia, I. Czuriga, I. Edes and Z. Papp. "Cell-to-cell variability in troponin I phosphorylation in a porcine model of pacing-induced heart failure." Basic Research in Cardiology 107, no.2 (2012): 244. DOI: 10.1007/s00395-012-0244-x. IF: 7.348

A. Darago, M. Fagyas, I. M. Siket, A. Facsko, Z. Megyesi, J. Kalasz, Z. Galajda, T. Szerafin, J. Harsfalvi, I. Edes, Z. Papp, A. Toth and J. Szentmiklosi. "Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery." Cardiovascular Therapeutics 30, no. 3 (2012): 136-144. DOI: 10.1111/j.1755-5922.2010.00252.x. IF: 2.353

G. Fürjes, G. Tóth, B. Peitl, R. Pórszász, B. Lelesz, R. Sári, A. Tóth, Z. Szilvássy and J. Németh. "Thrittene radioimmunoassay: description and application of a novel method." Journal of Radioanalytical and Nuclear Chemistry 292, no. 1 (2012): 113-118. IF: 1.52

B. Kolozsvári, É. Bakó, B. Bécsi, A. Kiss, Á. Czikora, A. Tóth, G. Vámosi, P. Gergely and F. Erdődi. "Calcineurin regulates endothelial barrier function by interaction with and dephosphorylation of myosin phosphatase." Cardiovascular Research 96, no. 3 (2012):494-503cvs255. DOI: 10.1093/cvr/cvs255. IF: 6.064

Z. Papp, D. Czuriga, L. Balogh, A. Balogh and A. Borbely. "How Cardiomyocytes Make the Heart Old." Current Pharmaceutical Biotechnology 13, no. 13 (2012): 2515-2521. IF: 2.805

Z. Papp, I. Edes, S. Fruhwald, S. G. De Hert, M. Salmenpera, H. Leppikangas, A. Mebazaa, G. Landoni, E. Grossini, P. Caimmi, A. Morelli, F. Guarracino, R. H. Schwinger, S. Meyer, L. Algotsson, B. G. Wikstrom, K. Jorgensen, G. Filippatos, J. T. Parissis, M. J. Gonzalez, A. Parkhomenko, M. B. Yilmaz, M. Kivikko, P. Pollesello and F. Follath. "Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan." International Journal of Cardiology 159, no. 2 (2012): 82-87. DOI: 10.1016/j.ijcard.2011.07.022. IF: 7.078
 

2011

T. Beleznai, A. Feher, D. Spielvogel, S. L. Lansman and Z. Bagi. "Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes." American Journal of Physiology Heart and Circulatory Physiology 300, no. 3 (2011): H777-783. DOI: 10.1152/ajpheart.00831.2010. IF: 3.708

D. Czuriga, Z. Papp, I. Czuriga and Á. Balogh. "Cardiac aging–a review." European Surgery 43, no. 2 (2011): 69-77. IF: 0.283

I. Falcao-Pires, N. Hamdani, A. Borbely, C. Gavina, C. G. Schalkwijk, J. van der Velden, L. van Heerebeek, G. J. Stienen, H. W. Niessen, A. F. Leite-Moreira and W. J. Paulus. "Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness." Circulation 124, no. 10 (2011): 1151-1159. DOI: 10.1161/CIRCULATIONAHA.111.025270. IF: 14.739

R. Fedor, L. Asztalos, L. Lőcsey, L. Szabó, I. Mányiné, M. Fagyas, E. Lizanecz and A. Tóth. "Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Predicts Left Ventricular Hypertrophy After Renal Transplantation." Transplantation Proceedings 43, no.4 (2011): 1259-1260. DOI: 10.1016/j.transproceed.2011.03.064. IF: 1.005

Y. Ait Mou, A. Toth, C. Cassan, D. Czuriga, P. P. de Tombe, Z. Papp, A. Lacampagne and O. Cazorla. "Beneficial effects of SR33805 in failing myocardium." Cardiovascular Research 91, no. 3 (2011): 412-419. DOI: 10.1093/cvr/cvr096. IF: 6.064

W. Sun, K. Liu, H. Ryu, D. W. Kang, Y. S. Kim, M. S. Kim, Y. Cho, R. S. Bhondwe, S. A. Thorat, H. S. Kim, L. V. Pearce, V. A. Pavlyukovets, R. Tran, M. A. Morgan, J. Lazar, C. B. Ryder, A. Toth, P. M. Blumberg and J. Lee. "2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure–activity relationships in the B and C-regions." Bioorganic & Medicinal Chemistry 20, no. 3 (2011): 1310-1318. DOI: 10.1016/j.bmc.2011.12.014. IF: 2.921

M. Szántó, I. Rutkai, C. Hegedűs, Á. Czikora, M. Rózsahegyi, B. Kiss, L. Virág, P. Gergely, A. Tóth and P. Bai. "Poly (ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction." Cardiovascular Research 92, no. 3 (2011): 430-438.n DOI: 10.1093/cvr/cvr246. IF: 6.064

T. Beleznai and Z. Bagi. "Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation." Vascular Pharmacology 56, no. 3-4 (2012): 115-121. DOI: 10.1016/j.vph.2011.11.003. IF: 1.986
 

2010

R. Fedor, L. Asztalos, L. Löcsey, L. Szabo, I. Manyine, M. Fagyas, E. Lizanecz and A. Tóth. "Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy." Transplantation Proceedings 42, no. 6 (2010): 2304-2308. DOI: 10.1016/j.transproceed.2010.05.020. IF: 0.993

A. Feher, I. Rutkai, T. Beleznai, Z. Ungvari, A. Csiszar, I. Edes and Z. Bagi. "Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity." Cardiovasc Research 87, no. 4 (2010): 732-739. DOI: 10.1093/cvr/cvq088. IF: 6.051

K. Sliwa, D. Hilfiker‐Kleiner, M. C. Petrie, A. Mebazaa, B. Pieske, E. Buchmann, V. Regitz‐Zagrosek, M. Schaufelberger, L. Tavazzi and D. J. Veldhuisen. "Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy." European Journal of Heart Failure 12, no. 8 (2010): 767-778. DOI: 10.1093/eurjhf/hfq120. IF: 4.512
 

2009

Z. Bagi, A. Feher and T. Beleznai. "Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species." Pharmacological Reports 61, no. 1 (2009): 99-104. IF: 2.086

A. Borbely, I. Falcao-Pires, L. van Heerebeek, N. Hamdani, I. Edes, C. Gavina, A. F. Leite-Moreira, J. G. Bronzwaer, Z. Papp, J. van der Velden, G. J. Stienen and W. J. Paulus. "Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium." Circulation Research 104, no. 6 (2009): 780-786. DOI: 10.1161/CIRCRESAHA.108.193326. IF: 9.214

A. Borbely, Z. Papp, I. Edes and W. J. Paulus. "Molecular determinants of heart failure with normal left ventricular ejection fraction." Pharmacological Reports 61, no. 1 (2009): 139-145. IF: 2.086

A. Borbely, L. van Heerebeek and W. J. Paulus. "Transcriptional and posttranslational modifications of titin: implications for diastole." Circulation Research 104, no. 1 (2009): 12-14. DOI: 10.1161/CIRCRESAHA.108.191130. IF: 9.214

H. K. Choi, S. Choi, Y. Lee, D. W. Kang, H. Ryu, H. J. Maeng, S. J. Chung, V. A. Pavlyukovets, L. V. Pearce, A. Toth, R. Tran, Y. Wang, M. A. Morgan, P. M. Blumberg and J. Lee. "Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists." Bioorganic & Medicinal Chemistry 17, no. 2 (2009): 690-698. DOI: 10.1016/j.bmc.2008.11.085. IF: 2.822

N. Hamdani, W. J. Paulus, L. van Heerebeek, A. Borbely, N. M. Boontje, M. J. Zuidwijk, J. G. Bronzwaer, W. S. Simonides, H. W. Niessen, G. J. Stienen and J. van der Velden. "Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction." European Heart Journal 30, no. 15 (2009): 1863-1872. DOI: 10.1093/eurheartj/ehp189. IF: 5.385

Z. Hertelendi, A. Toth, A. Borbely, Z. Galajda, I. Edes, A. Tosaki and Z. Papp. "The peroxynitrite evoked contractile depression can be partially reversed by antioxidants in human cardiomyocytes." Journal of Cellular and Molecular Medicine 13, no. 8B (2009): 2200-2209. DOI: 10.1111/j.1582-4934.2008.00445.x. IF: 5.228

A. Molnar, A. Borbely, D. Czuriga, S. M. Ivetta, S. Szilagyi, Z. Hertelendi, E. T. Pasztor, A. Balogh, Z. Galajda, T. Szerafin, K. Jaquet, Z. Papp, I. Edes and A. Toth. "Protein kinase C contributes to the maintenance of contractile force in human ventricular cardiomyocytes." Journal of Biological Chemistry 284, no. 2 (2009): 1031-1039. DOI: 10.1074/jbc.M807600200. IF: 5.328

M. S. Nieminen, P. Pollesello, G. Vajda and Z. Papp. "Effects of levosimendan on the energy balance: preclinical and clinical evidence." Journal of Cardiovascular Pharmacology 53, no. 4 (2009): 302-310. DOI: 10.1097/FJC.0b013e31819c9a17. IF: 2.826

A. Racz, Z. Veresh, N. Erdei, Z. Bagi and A. Koller. "Thromboxane A(2) contributes to the mediation of flow-induced responses of skeletal muscle venules: role of cyclooxygenases 1 and 2." Journal of Vascular Research 46, no. 5 (2009): 397-405. DOI: 10.1159/000194270. IF: 2.9

I. Rutkai, A. Feher, N. Erdei, D. Henrion, Z. Papp, I. Edes, A. Koller, G. Kaley and Z. Bagi. "Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes." Cardiovascular Research 83, no. 1 (2009): 148-154. DOI: 10.1093/cvr/cvp098. IF: 5.801

H. Ryu, J. O. Lim, D. W. Kang, L. V. Pearce, R. Tran, A. Toth, J. Lee and P. M. Blumberg. "Conformationally Constrained Analogues of N'-(4-t-Butylbenzyl)-N-(4-Methylsulfonylaminobenzyl) Thiourea as TRPV1 Antagonists." European Journal of Medicinal Chemistry 44, no. 1 (2009): 322-331. DOI: 10.1016/j.ejmech.2008.02.026. IF: 3.269

A. Toth, P. M. Blumberg and J. Boczán. "Anandamide and the vanilloid receptor (TRPV1)." Vitamins & Hormones 81 (2009): 389-419. DOI: 10.1016/S0083-6729(09)81015-7. IF: 2.439
 

2008

Z. Bagi, N. Erdei and A. Koller. "High intraluminal pressure via H2O2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors." American Journal of Physiology Heart and Circulatory Physiology 295, no. 2 (2008): H835-841. DOI: 10.1152/ajpheart.00205.2008. IF: 3.643

P. Birinyi, A. Tóth, I. Jóna, K. Acsai, J. Almássy, N. Nagy, J. Prorok, I. Gherasim, Z. Papp and Z. Hertelendi. "The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes." Cardiovascular Research 78, no. 3 (2008): 476-84 DOI: 10.1093/cvr/cvn031. IF: 5.947

I. F. Edes, A. Toth, G. Csanyi, M. Lomnicka, S. Chlopicki, I. Edes and Z. Papp. "Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44)." Journal of Molecular and Cellular Cardiology 45, no. 3 (2008): 363-372. DOI: 10.1016/j.yjmcc.2008.07.001. IF: 5.054

N. Hamdani, M. de Waard, A. E. Messer, N. M. Boontje, V. Kooij, S. van Dijk, A. Versteilen, R. Lamberts, D. Merkus, C. dos Remedios, D. J. Duncker, A. Borbely, Z. Papp, W. Paulus, G. J. Stienen, S. B. Marston and J. van der Velden. "Myofilament dysfunction in cardiac disease from mice to men." Journal of Muscle Research and Cell Motility 29, no. 6-8 (2008): 189-201. DOI: 10.1007/s10974-008-9160-y. IF: 1.993

É. Hegedüs, L. Imre, J. Pataki, E. Lizanecz, L. Székvölgyi, F. Fazakas, Z. Bacsó, A. Tóth, M. Szabó, Z. Seres and G. Szabó.  "Heteroduplex analysis using flow cytometric microbead assays to detect deletions, insertions, and single‐strand lesions." Cytometry Part A 73, no. 3 (2008): 238-245. DOI: 10.1002/cyto.a.20492. IF: 3.259

Z. Hertelendi, A. Toth, A. Borbely, Z. Galajda, J. van der Velden, G. J. Stienen, I. Edes and Z. Papp. "Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and its Ca2+ sensitivity in human cardiomyocytes." Antioxidants & Redox Signaling 10, no. 7 (2008): 1175-1184. DOI: 10.1089/ars.2007.2014. IF: 6.19

E. Jebelovszki, C. Kiraly, N. Erdei, A. Feher, E. T. Pasztor, I. Rutkai, T. Forster, I. Edes, A. Koller and Z. Bagi. "High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation." American Journal of Physiology Heart and Circulatory Physiology 294, no. 6 (2008): H2558-2564. DOI: 10.1152/ajpheart.01198.2007. IF: 3.643

T. Kark, Z. Bagi, E. Lizanecz, E. T. Pasztor, N. Erdei, A. Czikora, Z. Papp, I. Edes, R. Porszasz and A. Toth. "Tissue-specific regulation of microvascular diameter: opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1." Molecular Pharmacology 73, no. 5 (2008): 1405-1412. DOI: 10.1124/mol.107.043323. IF: 4.711

L. V. Pearce, A. Toth, H. Ryu, D. W. Kang, H.-K. Choi, M.-K. Jin, J. Lee and P. M. Blumberg. "Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors." Naunyn-Schmiedeberg's Archives of Pharmacology 377, no. 2 (2008): 149-157. DOI: 10.1007/s00210-007-0258-3. IF: 2.83

L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J. Ijsselmuiden, C. G. Schalkwijk, J. G. Bronzwaer, M. Diamant, A. Borbely, J. van der Velden, G. J. Stienen, G. J. Laarman, H. W. Niessen and W. J. Paulus. "Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension." Circulation 117, no. 1 (2008): 43-51. DOI: 10.1161/CIRCULATIONAHA.107.728550. IF: 14.595
 

2007

J. U. Chung, S. Y. Kim, J. O. Lim, H. K. Choi, S. U. Kang, H. S. Yoon, H. Ryu, D. W. Kang, J. Lee, B. Kang, S. Choi, A. Toth, L. V. Pearce, V. A. Pavlyukovets, D. J. Lundberg and P. M. Blumberg. "α-Substituted< i> N</i>-(4-< i> tert</i>-butylbenzyl)-< i> N</i>′-[4-(methylsulfonylamino) benzyl] thiourea analogues as potent and stereospecific TRPV1 antagonists." Bioorganic & Medicinal Chemistry 15, no. 18 (2007): 6043-6053. DOI: 10.1016/j.bmc.2007.06.041. IF: 2.624

I. F. Edes, D. Czuriga, G. Csanyi, S. Chlopicki, F. A. Recchia, A. Borbely, Z. Galajda, I. Edes, J. van der Velden, G. J. Stienen and Z. Papp. "Rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine, and porcine cardiomyocytes." American Journal of Physiology Regul Integrative and Comperative Physiology 293, no. 1 (2007): R20-29. DOI:org/10.1152/ajpregu.00537.2006. IF: 3.685

N. Erdei, Z. Bagi, I. Edes, G. Kaley and A. Koller. "H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice." American Journal of Physiology Heart and Circulatory Physiology 292, no. 1 (2007): H649-656. DOI: 10.1152/ajpheart.00596.2006. IF: 3.724

T. Fulop, E. Jebelovszki, N. Erdei, T. Szerafin, T. Forster, I. Edes, A. Koller and Z. Bagi. "Adaptation of vasomotor function of human coronary arterioles to the simultaneous presence of obesity and hypertension." Arteriosclerosis, Thrombosis, and Vascular Biology 27, no. 11 (2007): 2348-2354. DOI: 10.1161/ATVBAHA.107.147991. IF: 6.883

W. J. Paulus,  C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, A. Borbely, I. Edes, M. L. Handoko, S. Heymans, N. Pezzali, B. Pieske, K. Dickstein, A. G. Fraser and D. L. Brutsaert. "How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology." European Heart Journal 28, no. 20 (2007): 2539-2550. DOI: 10.1093/eurheartj/ehm037. IF: 7.286

P. Pollesello and Z. Papp. "The cardioprotective effects of levosimendan: preclinical and clinical evidence." Journal of Cardiovascular Pharmacology 50, no. 3 (2007): 257-263. DOI: 10.1097/FJC.0b013e3180986230. IF: 1.625

Ryu, H., M. K. Jin, S. Y. Kim, H. K. Choi, S. U. Kang, D. W. Kang, J. Lee, L. V. Pearce, V. A. Pavlyukovets, M. A. Morgan, R. Tran, A. Toth, D. J. Lundberg and P. M. Blumberg. "Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino) phenyl] propionamide analogues." Journal of Medicinal Chemistry 51, no. 1 (2007): 57-67. DOI: 10.1021/jm701049p. IF: 4.898

E. Toth, A. Racz, J. Toth, P. M. Kaminski, M. S. Wolin, Z. Bagi and A. Koller. "Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation." American Journal of Physiology Heart and Circulatory Physiology 293, no. 5 (2007): H3096-3104. DOI: 10.1152/ajpheart.01335.2006. IF: 3.724

J. Toth, A. Racz, P. M. Kaminski, M. S. Wolin, Z. Bagi and A. Koller. "Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone." Hypertension 49, no. 3 (2007): 563-568. DOI: 10.1161/01.HYP.0000256764.86208.3d. IF: 6.007
 

2006

A. Toth, Y. Wang, N. Kedei, R. Tran, L. V. Pearce, S. U. Kang, M. K. Jin, H. K. Choi, J. Lee and P. M. Blumberg. "Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1." Life Sciences 76, no. 25 (2005): 2921-2932. DOI: 10.1016/j.lfs.2004.10.056. IF: 2.512

Z. Bagi, N. Erdei, Z. Papp, I. Edes and A. Koller. "Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus." Pharmacological Reports 58, (2006) Suppl: 52-56. IF: 0.764

Z. Bagi, P. Hamar, M. Kardos and A. Koller. "Lack of flow-mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice." Lupus 15, no. 6 (2006): 326-334. DOI: 10.1191/0961203306lu2297oa. IF: 2.366

O. Cazorla, S. Szilagyi, N. Vignier, G. Salazar, E. Kramer, G. Vassort, L. Carrier and A. Lacampagne. "Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice." Cardiovasc Research 69, no. 2 (2006): 370-380. DOI: 10.1016/j.cardiores.2005.11.009. IF: 5.826

N. Erdei, Z. Papp, P. Pollesello, I. Edes and Z. Bagi. "The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles." British Journal of Pharmacology 148, no. 5 (2006): 696-702. DOI: 10.1038/sj.bjp.0706781. IF: 3.825

N. Erdei, A. Toth, E. T. Pasztor, Z. Papp, I. Edes, A. Koller and Z. Bagi. "High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion." American Journal of Physiology Heart and Circulatory Physiology 291, no. 5 (2006): H2107-2115. DOI: 10.1152/ajpheart.00389.2006. IF: 3.724

P. Kaheinen, P. Pollesello, Z. Hertelendi, A. Borbély, S. Szilágyi, E. Nissinen, H. Haikala and Z. Papp. "Positive Inotropic Effect of Levosimendan is Correlated to its Stereoselective Ca2+‐Sensitizing Effect but not to Stereoselective Phosphodiesterase Inhibition." Basic & clinical pharmacology & toxicology 98, no. 1 (2006): 74-78. DOI: 10.1111/j.1742-7843.2006.pto_231.x. IF: 1.788

J. Lazar, D. C. Braun, A. Toth, Y. Wang, L. V. Pearce, V. A. Pavlyukovets, P. M. Blumberg, S. H. Garfield, S. Wincovitch, H.-K. Choi and J. Lee. "Kinetics of penetration influence the apparent potency of vanilloids on TRPV1." Molecular pharmacology 69, no. 4 (2006): 1166-1173. DOI: 10.1124/mol.105.019158. IF: 4.469

E. Lizanecz, Z. Bagi, E. T. Pasztor, Z. Papp, I. Edes, N. Kedei, P. M. Blumberg and A. Toth. "Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1." Molecular Pharmacology 69, no. 3 (2006): 1015-1023. DOI: 10.1124/mol.105.015644. IF: 4.469

E. Lizanecz, E. T. Pasztor, A. Mohacsi, Z. Papp, I. Edes and A. Toth. "Mistyping of angiotensinogen M235T alleles." Hypertension Research 29, no. 3 (2006): 197-201. DOI: 10.1291/hypres.29.197. IF: 3.177

A. Molnar, A. Toth, Z. Bagi, Z. Papp, I. Edes, M. Vaszily, Z. Galajda, J. G. Papp, A. Varro, V. Szuts, Z. Lacza, D. Gero and C. Szabo. "Activation of the poly (ADP-ribose) polymerase pathway in human heart failure." Molecular Medicine 12, no. 7-8 (2006) : 143-152. DOI: 10.2119/2006-00043.Molnar. IF: 2.708

T. Szerafin, N. Erdei, T. Fulop, E. T. Pasztor, I. Edes, A. Koller and Z. Bagi. "Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus." Circulation Research 99, no. 5 (2006): e12-17. DOI: 10.1161/01.RES.0000241051.83067.62. IF: 9.854

J. van der Velden, N. A. Narolska, R. R. Lamberts, N. M. Boontje, A. Borbély, R. Zaremba, J. G. Bronzwaer, Z. Papp, K. Jaquet and W. J. Paulus. "Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium." Cardiovascular Research 69, no. 4 (2006): 876-887. DOI: 10.1016/j.cardiores.2005.11.021. IF: 5.826

L. van Heerebeek, A. Borbely, H. W. Niessen, J. G. Bronzwaer, J. van der Velden, G. J. Stienen, W. A. Linke, G. J. Laarman and W. J. Paulus. "Myocardial structure and function differ in systolic and diastolic heart failure." Circulation 113, no. 16 (2006): 1966-1973. DOI: 10.1161/CIRCULATIONAHA.105.587519. IF: 10.94
 

2005

Z. Bagi, N. Erdei, A. Toth, W. Li, T. H. Hintze, A. Koller and G. Kaley. "Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins." Arteriosclerosis, Thrombosis, and Vascular Biology 25, no. 8 (2005): 1610-1616. DOI: 10.1161/01.ATV.0000172688.26838.9f. IF: 7.053

Z. Bagi, J. A. Frangos, J. C. Yeh, C. R. White, G. Kaley and A. Koller. "PECAM-1 mediates NO-dependent dilation of arterioles to high temporal gradients of shear stress." Arteriosclerosis, Thrombosis, and Vascular Biology 25, no. 8 (2005): 1590-1595. DOI: 10.1161/01.ATV.0000170136.71970.5f. IF: 7.053

J. Barta, A. Toth, I. Edes, M. Vaszily, J. G. Papp, A. Varro and Z. Papp. "Calpain-1-sensitive myofibrillar proteins of the human myocardium." Molecular and Cellular Biochemistry 278, no. 1-2 (2005): 1-8. DOI: 10.1007/s11010-005-1370-7. IF: 1.681

A. Borbely, A. Toth, I. Edes, L. Virag, J. G. Papp, A. Varro, W. J. Paulus, J. van der Velden, G. J. Stienen and Z. Papp. "Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells." Cardiovascular Research 67, no. 2 (2005): 225-233. DOI: 10.1016/j.cardiores.2005.03.025. IF: 5.283

A. Borbely, J. van der Velden, Z. Papp, J. G. Bronzwaer, I. Edes, G. J. Stienen and W. J. Paulus.  "Cardiomyocyte stiffness in diastolic heart failure." Circulation 111, no. 6 (2005): 774-781. DOI: 10.1161/01.CIR.0000155257.33485.6D. IF: 11.632

O. Cazorla, S. Szilagyi, J. Y. Le Guennec, G. Vassort and A. Lacampagne. "Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction." FASEB Journal 19, no. 1 (2005): 88-90. DOI: 10.1096/fj.04-2066fje. IF: 7.064

J. Lee, M. K. Jin, S. U. Kang, S. Y. Kim, J. Lee, M. Shin, J. Hwang, S. Cho, Y. S. Choi and H. K. Choi, S. E. Kim, Y. G. Suh, Y. S. Lee, Y. H. Kim, H. J. Ha, A. Toth, L. V. Pearce, R. Tran, T. Szabo, J. D. Welter, D. J Lundberg, Y. Wang, J. Lazar, V. A. Pavlyukovets, M. A. Morgan and P. M. Blumberg. "Analysis of structure–activity relationships for the ‘B-region’of< i> N</i>-(4-< i> t</i>-butylbenzyl)-< i> N</i>′-[4-(methylsulfonylamino) benzyl]-thiourea analogues as TRPV1 antagonists." Bioorganic & Medicinal Chemistry Letters 15, no. 18 (2005): 4143-4150. DOI: 10.1016/j.bmcl.2005.06.006. IF: 2.478

J. Lee, S. U. Kang, M. J. Kil, M. Shin, J. O. Lim, H. K. Choi, M. K. Jin, S. Y. Kim, S. E. Kim, Y. S. Lee, K. H. Min, Y. H. Kim, H. J. Ha, R. Tran, J. D. Welter, J. D. Welter, Y. Wang, T. Szabo, L. V. Pearce, D. J.  Lundberg, A. Toth, V. A. Pavlyukovets, M. A. Morgan and P. M. Blumberg.  "Analysis of structure–activity relationships for the ‘A-region’of< i> N</i>-(4-< i> t</i>-butylbenzyl)-< i> N</i>′-[4-(methylsulfonylamino) benzyl] thiourea analogues as TRPV1 antagonists." Bioorganic & Medicinal Chemistry Letters 15, n. 18 (2005): 4136-4142. DOI: 10.1016/j.bmcl.2005.06.009. IF: 2.478

Z. Papp, K. Csapo, P. Pollesello, H. Haikala and I. Edes. "Pharmacological mechanisms contributing to the clinical efficacy of levosimendan." Cardiovasc Drug Reviews 23, no. 1 (2005): 71-98. IF: 2.122

S. Szilagyi, P. Pollesello, J. Levijoki, H. Haikala, I. Bak, A. Tosaki, A. Borbely, I. Edes and Z. Papp. "Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone." Journal of Cardiovascular Pharmacology 46, no. 3 (2005): 369-376. IF: 1.313

A. Toth, J. Boczan, N. Kedei, E. Lizanecz, Z. Bagi, Z. Papp, I. Edes, L. Csiba and P. M. Blumberg.  "Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain." Molecular Brain Research 135, no.1-2 (2005): 162-168. DOI: 10.1016/j.molbrainres. 2004.12.003. IF: 1.585
 

2004

Z. Bagi, E. Toth, A. Koller and G. Kaley. "Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4)." American Journal of Physiology Heart and Circulation Physiology 287, no. 2 (2004): H626-633. DOI: 10.1152/ajpheart.00074.2004. IF: 3.539

C. Brodie, R. Steinhart, G. Kazimirsky, H. Rubinfeld, T. Hyman, J. N. Ayres, G. M. Hur, A. Toth, D. Yang and S. H. Garfield. "PKCδ associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters." Molecular Pharmacology 66, no.1 (2004): 76-84. DOI: 10.1124/mol.66.1.76. IF: 5.080

N. R. Gavva, L. Klionsky, Y. Qu, L. Shi, R. Tamir, S. Edenson, T. Zhang, V. N. Viswanadhan, A. Toth, L. V. Pearce, T. W. Vanderah, F. Porreca, P. M. Blumberg, J. Lile, Y. Sun, K. Wild, J. C. Louis and J. J. Treanor. "Molecular determinants of vanilloid sensitivity in TRPV1." Journal of Biological Chemistry 279, no. 19 (2004): 20283-20295. DOI: 10.1074/jbc.M312577200. IF: 6.355

N. Kedei, D. J. Lundberg, A. Toth, P. Welburn, S. H. Garfield and P. M. Blumberg. "Characterization of the interaction of ingenol 3-angelate with protein kinase C." Cancer Research 64, no. 9 (2004): 3243-3255. DOI: 10.1158/0008-5472.CAN-03-3403. IF: 7.690

A. Koller and Z. Bagi. "Nitric oxide and H2O2 contribute to reactive dilation of isolated coronary arterioles." American Journal of Physiology Heart and Circulation Physiology 287, no. 6 (2004): H2461-2467. DOI: 10.1152/ajpheart.00295.2004. IF: 3.539

J. Lee, S. U. Kang, H. K. Choi, J. Lee, J. O. Lim, M. J. Kil, M. K. Jin, K. P. Kim, J. H. Sung, S. J. Chung, H. J. Ha, Y. H. Kim, L. V. Pearce, R. Tran, D. J. Lundberg, Y. Wang, A. toth, P. M. Blumberg. "Analysis of structure–activity relationships for the ‘B-region’of< i> N</i>-(3-acyloxy-2-benzylpropyl)-< i> N</i>< sup>′</sup>-[4-(methylsulfonylamino) benzyl] thiourea analogues as vanilloid receptor antagonists: discovery of an< i> N</i>-hydroxythiourea analogue with potent analgesic activity." Bioorganic & Medicinal Chemistry Letters 14, no. 9 (2004): 2291-2297. DOI: 10.1016/j.bmcl.2004.02.002. IF: 2.333

J. Lee, S. U. Kang, J. O. Lim, H. K. Choi, M. K. Jin, A. Toth, L. V. Pearce, R. Tran, Y. Wang, T. Szabo and P. M. Blumberg. "< i> N</i>-[4-(Methylsulfonylamino) benzyl] thiourea analogues as vanilloid receptor antagonists: analysis of structure–activity relationships for the ‘C-Region’." Bioorganic & Medicinal Chemistry 12, no. 2 (2004): 371-385. DOI: 10.1016/j.bmc.2003.10.047. IF: 2.018

J. Lee, S. Y. Kim, J. Lee, M. Kang, M. J. Kil, H. K. Choi, M. K. Jin, Y. Wang, A. Toth, L. V. Pearce, D. J. Lundberg, R. Tran, P.M. Blumberg. "Analysis of structure–activity relationships with the< i> N</i>-(3-acyloxy-2-benzylpropyl)-< i> N</i>< sup>′</sup>-[4-(methylsulfonylamino) benzyl] thiourea template for vanilloid receptor 1 antagonism." Bioorganic & Medicinal Chemistry 12, no. 13 (2004): 3411-3420. DOI: 10.1016/j.bmc.2004.04.040. IF: 2.018

J. Lee, S. Y. Kim, S. Park, J. O. Lim, J. M. Kim, M. Kang, J. Lee, S. U. Kang, H. K. Choi M. K. Jin, J. D. Welter, T. Szabo, R. Tran, L. V. Pearce, A. Toth and P. M. Blumberg. "Structure–activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding." Bioorganic & Medicinal chemistry 12, no. 5 (2004): 1055-1069. DOI: 10.1016/j.bmc.2003.12.005. IF: 2.018

Z. Papp, J. Van Der Velden, A. Borbely, I. Edes and G. J. Stienen. "Effects of Ca2+ -sensitizers in permeabilized cardiac myocytes from donor and end-stage failing human hearts." Journal of Muscle Research and Cell Motility 25, no. 3 (2004): 219-224. IF: 1.721

C. J. Pemberton, H. Tokola, Z. Bagi, A. Koller, J. Pöntinen, A. Ola, O. Vuolteenaho, I. Szokodi and H. Ruskoaho. "Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion." American Journal of Physiology Heart and Circulation Physiology 287, no. 4 (2004): H1522-1529. DOI: 10.1152/ajpheart.00193.2004. IF: 3.539

S. Szilagyi, P. Pollesello, J. Levijoki, P. Kaheinen, H. Haikala, I. Edes and Z. Papp. "The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig." European Journal of Pharmacology 486, no. 1 (2004): 67-74. DOI: 10.1016/j.ejphar.2003.12.005. IF: 2.432

A. Toth, P. M. Blumberg, Z. Chen and A. P. Kozikowski. "Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population." Molecular Pharmacology 65, no. 2 (2004): 282-291. DOI: 10.1124/mol.65.2.282. IF: 5.08

Y. Wang, N. Kedei, M. Wang, Q. J. Wang, A. R. Huppler, A. Toth, R. Tran and P. M. Blumberg. "Interaction between protein kinase Cμ and the vanilloid receptor type 1." Journal of Biological Chemistry 279, no. 51 (2004): 53674-53682. DOI: 10.1074/jbc.M410331200. IF: 6.355
 

2003

J. Barta, A. Toth, K. Jaquet, A. Redlich, I. Edes and Z. Papp. "Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy." Molecular and Cellular Biochemistry 251, no. 1-2 (2003): 83-88. IF: 1.763

A. Bódi, S. Szilagyi, I. Edes and Z. Papp. "The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation." General Physiology and Biophysics 22, no. 3 (2003): 313-327. IF: 0.794

J. Lee, J. Lee, M. Kang, M. Shin, J. M. Kim, S. U. Kang, J. O. Lim, H. K. Choi, Y. G. Suh, H. G. Park, U. Oh, H. D. Kim, Y. H. Park, H. J. Ha, Y. H. Kim, A. Toth, Y. Wang, R. Tran, L. V. Pearce, D. J. Lundberg and P. M. Blumberg "N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino) benzyl] thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor." Journal of Medicinal Chemistry 46, no. 14 (2003): 3116-3126. DOI: 10.1021/jm030089u. IF: 4.820

A. Tóth, N. Kedei, Y. Wang and P. M. Blumberg. "Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat." Life Sciences 73, no. 4 (2003): 487-498. DOI: 10.1016/S0024-3205(03)00310-2. IF: 1.944
J. Van der Velden, Z. Papp, N. M. Boontje, R. Zaremba, J. W. de Jong, P. M. Janssen, G. Hasenfuss and G. J. Stienen (2003). "The effect of myosin light chain 2 dephosphorylation on Ca2+-sensitivity of force is enhanced in failing human hearts." Cardiovascular Research 57, no. 2 (2003): 505-514. IF: 5.164

J. Van der Velden, J, Z. Papp, N. M. Boontje, R. Zaremba, J. W. de Jong, P. M. Janssen, G. Hasenfuss and G. J. Stienen. Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium. Molecular and Cellular Aspects of Muscle Contraction, Springer US: 3-15. IF: 0.642

J. Van der Velden, Z. Papp, R. Zaremba, N. M. Boontje, J. W. de Jong, V. J. Owen, P. B. Burton, P. Goldmann, K. Jaquet and G. J. Stienen. "Increased Ca 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins." Cardiovasc Research 57, no. 1 (2003): 37-47. IF: 5.164

Y. Wang, A. Toth, R. Tran, T. Szabo, J. D. Welter, P. M. Blumberg, J. Lee, S. U. Kang, J. O. Lim and J. Lee. "High-affinity partial agonists of the vanilloid receptor." Molecular Pharmacology 64, no. 2 (2003): 325-333. DOI: 10.1124/mol.64.2.325. IF: 5.650
 

2002

A. Tóth, N. Kedei, T. Szabó, Y. Wang and P. M. Blumberg. "Thapsigargin binds to and inhibits the cloned vanilloid receptor-1." Biochemical and Biophysical Research Communications 293, no. 2 (2002): 777-782. DOI: 10.1016/S0006-291X (02) 00293-0. IF: 2.935

J. Van der Velden, N. M. Boontje, Z. Papp, L. J. Klein, F. C. Visser, J. W. de Jong, V. J. Owen, P. B. Burton and G. J. Stienen. "Calcium sensitivity of force in human ventricular cardiomyocytes from donor and failing hearts." Basic Research in Cardiology 97, no.1 (2002): I118-I126. doi: 10.1016/j.abb.2012.12.004. IF: 1.994

Y. Wang, T. Szabo, J. D. Welter, A. Toth, R. Tran, J. Lee, S. U. Kang, Y. G. Suh, P. M. Blumberg and J. Lee. "High affinity antagonists of the vanilloid receptor." Molecular Pharmacology 62, no. 4 (2002): 947-956. doi: 10.1124/mol.62.4.947. IF: 5.480
 

2001

Z. Papp, J. Barta and G. J. Stienen. "Troponin I degradation and myocardial stunning." Circulation 104, no. 25 (2001): e157. IF: 10.517